Purchases and Sales Made in Q3 2022 in Entrada Therapeutics, Inc. (TRDA)
This table provides information about the institutional ownership of Entrada Therapeutics, Inc. (TRDA) during Q3 2022. The information is specifically focused on institutions that hold shares of Entrada Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
BUY
|
- |
535K+ 21.93% |
$5.16M - $8.42M
|
2.97M
$33.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Step Stone Group LP
La Jolla, CA |
BUY
|
- |
126K+ 19.89% |
$1.22M - $1.99M
|
761K
$8.63M
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
108K+ 14.14% |
$1.04M - $1.7M
|
870K
$9.86M
|
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
BUY
|
- |
95.2KNew |
$919K - $1.5M
|
95.2K
$1.08M
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
82.6K+ 127.07% |
$797K - $1.3M
|
148K
$1.67M
|
|
|
Nov 14, 2022
Q3 2022
|
Laurion Capital Management LP
New York, NY |
BUY
|
- |
70K+ 54.24% |
$676K - $1.1M
|
199K
$2.26M
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
65.3K+ 64.21% |
$631K - $1.03M
|
167K
$1.89M
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
45.1K+ 105.36% |
$435K - $710K
|
87.9K
$995K
|
|
|
Nov 14, 2022
Q3 2022
|
Fred Alger Management, LLC
New York, NY |
BUY
|
- |
18KNew |
$173K - $283K
|
18K
$203K
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
13.7K+ 83.72% |
$132K - $215K
|
30K
$340K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
4.31K+ 0.97% |
$41.6K - $67.9K
|
450K
$5.1M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
4.31K+ 0.97% |
$41.6K - $67.9K
|
450K
$5.1M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
3.1K+ 10.27% |
$29.9K - $48.9K
|
33.3K
$377K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.51KNew |
$24.2K - $39.5K
|
2.51K
$28.4K
|
|
|
Nov 07, 2022
Q3 2022
|
Td Asset Management Inc
|
BUY
|
- |
1.82K+ 3.16% |
$17.6K - $28.7K
|
59.5K
$674K
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
- |
1.49K+ 1584.04% |
$14.4K - $23.5K
|
1.58K
$17.9K
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
1.18K+ 3275.0% |
$11.4K - $18.6K
|
1.22K
$13.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
52+ 46.02% |
$502 - $820
|
165
$1.87K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-869- 46.37% |
$8.39K - $13.7K
|
1.01K
$11.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-9.03K- 69.47% |
$87.1K - $142K
|
3.97K
$44.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-10.7K- 50.3% |
$103K - $168K
|
10.5K
$119K
|
|
|
Nov 14, 2022
Q3 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
SELL
|
- |
-21.5K- 3.24% |
$208K - $339K
|
642K
$7.28M
|
|
|
Nov 10, 2022
Q3 2022
|
Nan Fung Group Holdings LTD
Central, K3 |
SELL
|
- |
-32K- 18.43% |
$309K - $504K
|
142K
$1.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-529K- 34.42% |
$5.1M - $8.33M
|
1.01M
$11.4M
|